Brad Reifler Explains Why Investors Should Mull Over Canada’s Cannabis Index

According to financial analyst, Brad Reifler, too few investors are taking advantage of cross-border stocks. PR Newswire said that Brad Reifler, CEO of Forefront Capital has been boosting financial portfolios for the wealthy for over twenty years and he believes, while there is risk, the cannabis market is looking to another great year.

Many investors are storming Canada’s cannabis industry because of record gains. 2016 was spectacular and analyst are estimating that the majority of Canada’s pharmaceutical cannabis shares could see record gains of well over 100 percent. Learn more about Brad Reifler: http://www.bloomberg.com/research/stocks/private/person.asp?personId=11479591&privcapId=140440171

This includes Aurora cannabis, a company which was discovered in 2015 as a stable investment opportunity. In 2015, it was a small startup and shares were just 40 cents. In the last quarter of 2016, shares soared 300 percent. Aurora now is the second-highest market value of all Canadian pharmaceutical cannabis shares. It’s currently a 750 million dollar company.

“Marijuana shares are currently regularly among the top traders on the Canadian Stock Exchange,” says Brad Reifler. The so-called “Marijuana Index” in which 29 companies are included, has roughly doubled over the past six months, and the cumulative market capitalization of all companies included in the index is approaching the mark of $2 billion dollars.

Buying Canadian Cannabis Stocks

Not all brokers are embracing marijuana stocks, thus requiring many investors to trade electronically, and many can be purchased on the OTC. However, these stocks are quite volatile. Shares have been on a boom, going skyward, and then investors realize a quick crash.

The cannabis industry is one of the fastest growing sectors in the economy, but cannabis stocks are definitely not for the squeamish, and it appears medical marijuana stocks are more stable. If novice investors are looking to take a chance, shares of pharmaceutical-based cannabis shares are a better choice.

For more than 30 years, Brad Reifler has been guiding investors on building substantial portfolios. He founded one of New York’s most successful firms, Forefront Advisory, and is currently President and CEO. Prior to working at Forefront, Brad Reifler was CEO at Pali Capital from 1995 to 2008.

According to Barrons, Brad Reifler, a financial analyst, is a graduate of Bowdoin College in Maine, and holds Series 3, 7, 24 and 63 regulatory licenses. He holds memberships in The Global Leaders, Hedge Fund Group, and Alternate Investments, and is a leader in his industry.

Comments are closed, but trackbacks and pingbacks are open.